References
- Barnett, A. (2006). DPP‐4 inhibitors and their potential role in the management of type 2 diabetes. International Journal of Clinical Practice, 60(11), 1454–1470. https://doi.org/10.1111/j.1742-1241.2006.01178.x
- Bennett, W. L., Maruthur, N. M., Singh, S., Segal, J. B., Wilson, L. M., Chatterjee, R., Marinopoulos, S. S., Puhan, M. A., Ranasinghe, P., Block, L., Nicholson, W. K., Hutfless, S., Bass, E. B., & Bolen, S. (2011). Comparative effectiveness and safety of medications for type 2 diabetes: An update including new drugs and 2-drug combinations. Annals of Internal Medicine, 154(9), 602–613. https://doi.org/10.7326/0003-4819-155-1-201107050-00016
- Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., Sacerdoti, F. D., & Salmon, J. K. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters In SC’06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing (pp. 43–43). IEEE. https://doi.org/10.1109/SC.2006.54
- Brutsaert, E., Carey, M., & Zonszein, J. (2014). The clinical impact of inpatient hypoglycemia. Journal of Diabetes and Its Complications, 28(4), 565–572. https://doi.org/10.1016/j.jdiacomp.2014.03.002
- Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., & Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Journal of Computer-Aided Molecular Design, 20(10-11), 647–671. https://doi.org/10.1007/s10822-006-9087-6
- Dixon, S. L., Smondyrev, A. M., & Rao, S. N. (2006). PHASE: A novel approach to pharmacophore modeling and 3D database searching. Chemical Biology & Drug Design, 67(5), 370–372. https://doi.org/10.1111/j.1747-0285.2006.00384.x
- Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein − ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/10.1021/jm051256o
- Guttula, P. K., Agrawal, K., Natarajan, P., & Gupta, M. K. (2019). Pharmacophore modeling coupled with Scaffold hopping to identify novel and potent Ribosomal S6 Kinase (RSK2) protein antagonists as anti-cancer agents. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/10.1080/07391102.2019.1689172
- Hamel, E. (2003). Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin. Cell Biochemistry and Biophysics, 38(1), 1–21. (
- Jana, S., & Singh, S. K. (2019). Identification of human tau-tubulin kinase 1 inhibitors: An integrated e-pharmacophore-based virtual screening and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 38 (3), 886–900. https://doi.org/10.1080/07391102.2019.1590242
- Kirchmair, J., Markt, P., Distinto, S., Wolber, G., & Langer, T. (2008). Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes? Journal of Computer-Aided Molecular Design, 22(3-4), 213–228.
- Kondo, T., Nekado, T., Sugimoto, I., Ochi, K., Takai, S., Kinoshita, A., Hatayama, A., Yamamoto, S., Kawabata, K., Nakai, H., & Toda, M. (2008). Discovery of long-acting N-(cyanomethyl)-N-alkyl-L-prolinamide inhibitors of dipeptidyl peptidase IV. Bioorganic & Medicinal Chemistry, 16(1), 190–208. https://doi.org/10.1016/j.bmc.2007.10.005
- Kondo, T., Nekado, T., Sugimoto, I., Ochi, K., Takai, S., Kinoshita, A., Hatayama, A., Yamamoto, S., Kishikawa, K., Nakai, H., & Toda, M. (2008). Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group. Bioorganic & Medicinal Chemistry, 16(4), 1613–1631. https://doi.org/10.1016/j.bmc.2007.11.031
- Kondo, T., Nekado, T., Sugimoto, I., Ochi, K., Takai, S., Kinoshita, A., Tajima, Y., Yamamoto, S., Kawabata, K., Nakai, H., & Toda, M. (2007). Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration. Bioorganic & Medicinal Chemistry, 15(7), 2631–2650. https://doi.org/10.1016/j.bmc.2007.01.041
- Kumar, A., Rathi, E., & Kini, S. G. (2019). Identification of potential tumour-associated carbonic anhydrase isozyme IX inhibitors: Atom-based 3D-QSAR modelling, pharmacophore-based virtual screening and molecular docking studies. Journal of Biomolecular Structure and Dynamics, 38(7), 1–15. https://doi.org/10.1080/07391102.2019.1626285
- Malchoff, C. D. (1991). Diagnosis and classification of diabetes mellitus. Connecticut Medicine, 55(11), 625–629.
- Martyna, G. J. (1994). Remarks on ‘‘Constant-temperature molecular dynamics with momentum conservation. Physical Review E, 50(4), 3234–3236. https://doi.org/10.1103/PhysRevE.50.3234
- Matubayasi, N., & Nakahara, M. (1999). Reversible molecular dynamics for rigid bodies and hybrid Monte Carlo. The Journal of Chemical Physics, 110(7), 3291–3301. https://doi.org/10.1063/1.478194
- Muthumanickam, S., Langeswaran, K., Sangavi, P., & Boomi, P. (2020). Screening of inhibitors as potential remedial against Ebolavirus infection: Pharmacophore-based approach. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–18. https://doi.org/10.1080/07391102.2020.1715260.
- Nain, Z., Sayed, S. B., Karim, M. M., Islam, M. A., & Adhikari, U. K. (2019). Energy-optimized pharmacophore coupled virtual screening in the discovery of quorum sensing inhibitors of LasR protein of Pseudomonas aeruginosa. Journal of Biomolecular Structure and Dynamics, 1–15. https://doi.org/10.1080/07391102.2019.1700168
- Nathan, D. M., Buse, J. B., Davidson, M. B., Heine, R. J., Holman, R. R., Sherwin, R., & Zinman, B. (2006). Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 29(8), 1963–1972. https://doi.org/10.2337/dc06-9912
- Naz, S., Farooq, U., Khan, S., Sarwar, R., Mabkhot, Y. N., Saeed, M., Alsayari, A., Muhsinah, A. B., & Ul-Haq, Z. (2020). Pharmacophore model based virtual screening, docking, biological evaluation and molecular dynamics simulations for inhibitors discovery against α-tryptophan synthase from mycobacterium tuberculosis. Journal of Biomolecular Structure and Dynamics, (just-accepted), 1–15. https://doi.org/10.1080/07391102.2020.1715259.
- Neumiller, J. J. (2009). Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors. Journal of the American Pharmacists Association, 49(5), S16–S29. https://doi.org/10.1331/JAPhA.2009.09078
- Pathak, R., & Bridgeman, M. B. (2010). Dipeptidyl peptidase-4 (DPP-4) inhibitors in the management of diabetes. P & T: A Peer-Reviewed Journal for Formulary Management, 35(9), 509–513.
- Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/10.1007/s10822-013-9644-8
- Sastry, G. M., Dixon, S. L., & Sherman, W. (2011). Rapid shape-based ligand alignment and virtual screening method based on atom/feature-pair similarities and volume overlap scoring. Journal of Chemical Information and Modeling, 51(10), 2455–2466. https://doi.org/10.1021/ci2002704
- Sebokova, E., Christ, A. D., Boehringer, M., & Mizrahi, J. (2007). Dipeptidyl peptidase IV inhibitors: The next generation of new promising therapies for the management of type 2 diabetes. Current Topics in Medicinal Chemistry, 7(6), 547–555.
- Shen, M., LeTiran, A., Xiao, Y., Golbraikh, A., Kohn, H., & Tropsha, A. (2002). Quantitative structure − activity relationship analysis of functionalized amino acid anticonvulsant agents using k nearest neighbor and simulated annealing PLS methods. Journal of Medicinal Chemistry, 45(13), 2811–2823. https://doi.org/10.1021/jm010488u
- Shivakumar, D., Williams, J., Wu, Y., Damm, W., Shelley, J., & Sherman, W. (2010). Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. Journal of Chemical Theory and Computation, 6(5), 1509–1519. https://doi.org/10.1021/ct900587b
- Stein, S. A., Lamos, E. M., & Davis, S. N. (2013). A review of the efficacy and safety of oral antidiabetic drugs. Expert Opinion on Drug Safety, 12(2), 153–175.
- Teli, M. K., & Rajanikant, G. K. (2012). Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 27(4), 558–570.
- Tice, C. M. (2001). Selecting the right compounds for screening: Does Lipinski’s Rule of 5 for pharmaceuticals apply to agrochemicals? Pest Management Science, 57(1), 3–16. https://doi.org/10.1002/1526-4998(200101)57:1 < 3::AID-PS269 > 3.0.CO;2-6
- Vanajothi, R., Hemamalini, V., Jeyakanthan, J., & Premkumar, K. (2019). Ligand-based pharmacophore mapping and virtual screening for identification of potential discoidin domain receptor 1 inhibitors. Journal of Biomolecular Structure and Dynamics, 1–9. https://doi.org/10.1080/07391102.2019.1640132
- Yeh, T.-K., Tsai, T.-Y., Hsu, T., Cheng, J.-H., Chen, X., Song, J.-S., Shy, H.-S., Chiou, M.-C., Chien, C.-H., Tseng, Y.-J., Huang, C.-Y., Yeh, K.-C., Huang, Y.-L., Huang, C.-H., Huang, Y.-W., Wang, M.-H., Tang, H.-K., Chao, Y.-S., Chen, C.-T., & Jiaang, W.-T. (2010). ( 2S, 4S)-1-[2-(1, 1-Dimethyl-3-oxo-3-pyrrolidin-1-yl-propylamino) acetyl]-4-fluoro-pyrrolidine-2-carbonitrile: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV. Bioorganic & Medicinal Chemistry Letters, 20(12), 3596–3600. https://doi.org/10.1016/j.bmcl.2010.04.124